Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Explained: Benefits, Safety & Oral vs Injectable Options The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and We have received an uptick in questions related to this substance. We felt it was best to share our policy here to bring attention to it. . OCB adheres to WADA guidelines DOJ & FDA Vape Raids: Impact on Retailers & Distributors Token of Trust